- Home
- INO vs AMTX Comparison
INO vs AMTX Comparison
Compare INO & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- AMTX
- Stock Information
- Founded
- INO 1979
- AMTX 2005
- Country
- INO United States
- AMTX United States
- Employees
- INO N/A
- AMTX N/A
- Industry
- INO Medical/Dental Instruments
- AMTX Major Chemicals
- Sector
- INO Health Care
- AMTX Industrials
- Exchange
- INO Nasdaq
- AMTX Nasdaq
- Market Cap
- INO 110.7M
- AMTX 127.9M
- IPO Year
- INO 1998
- AMTX N/A
- Fundamental
- Price
- INO $1.96
- AMTX $2.98
- Analyst Decision
- INO Buy
- AMTX Strong Buy
- Analyst Count
- INO 6
- AMTX 5
- Target Price
- INO $16.33
- AMTX $12.95
- AVG Volume (30 Days)
- INO 1.2M
- AMTX 665.5K
- Earning Date
- INO 11-14-2024
- AMTX 11-12-2024
- Dividend Yield
- INO N/A
- AMTX N/A
- EPS Growth
- INO N/A
- AMTX N/A
- EPS
- INO N/A
- AMTX N/A
- Revenue
- INO $203,413.00
- AMTX $291,400,000.00
- Revenue This Year
- INO N/A
- AMTX $69.05
- Revenue Next Year
- INO $2,290.97
- AMTX $49.46
- P/E Ratio
- INO N/A
- AMTX N/A
- Revenue Growth
- INO N/A
- AMTX 59.51
- 52 Week Low
- INO $1.91
- AMTX $2.10
- 52 Week High
- INO $14.75
- AMTX $7.03
- Technical
- Relative Strength Index (RSI)
- INO 12.76
- AMTX 38.21
- Support Level
- INO $3.96
- AMTX $2.87
- Resistance Level
- INO $4.08
- AMTX $3.16
- Average True Range (ATR)
- INO 0.25
- AMTX 0.22
- MACD
- INO -0.19
- AMTX -0.11
- Stochastic Oscillator
- INO 1.85
- AMTX 13.01
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.